UISH 001

Drug Profile

UISH 001

Alternative Names: BTL-hs; UISH-001

Latest Information Update: 22 Sep 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Beech Tree Labs
  • Class Antidiuretics
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Muscular dystrophies
  • No development reported Urinary incontinence

Most Recent Events

  • 22 Sep 2015 No recent reports on development identified - Phase-I/II for Urinary incontinence in USA (Sublingual)
  • 06 Nov 2012 Efficacy & adverse events data from a phase I/IIa trial in Urinary incontinence released by Beech Tree Labs
  • 31 May 2012 Beech Tree Labs completes a phase I/IIa trial in Urinary incontinence in USA (NCT01340066)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top